Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NJ › Bayonne › NPI 1821101239
Hospital

Ijkg Opco LLC

Ijkg Opco LLC was paid $17.54M by Medicaid between Jan 2018 and Dec 2024, across 211 billing codes. Its largest line is G0378, Hospital observation service, per hour — 19% of everything it billed.

33Billing provider infoIJKG OPCO LLC
BAYONNE, NJ 07002
33aNPI1821101239assigned 08/17/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$17.54M
24GClaims595,835
24DCodes billed211
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in New Jersey

Rank by total paid#56 of 93
Median peer was paid$30.60M
This provider vs. median0.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201897,333$3.89M
201986,630$3.31M
202059,000$1.99M
202171,001$2.33M
2022107,296$2.52M
2023107,844$1.89M
2024incomplete66,731$1.61M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
G0378 Hospital observation service, per hour 19% 5,671 3,878 $3.30M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 19% 21,190 19,014 $3.28M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 14% 12,821 11,683 $2.41M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 9.4% 9,362 8,300 $1.65M
99282 Emergency department visit for the evaluation and management, low to moderate severity 6.1% 10,378 9,194 $1.06M
OP250 4.2% 40,638 27,995 $732K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.6% 2,098 1,876 $276K
93017 1.5% 1,910 1,743 $266K
70450 Computed tomography, head or brain; without contrast material 1.5% 5,377 4,845 $265K
0202U Oncology (prostate), multianalyte, gene expression profiling 1.3% 3,606 3,262 $234K
80053 Comprehensive metabolic panel 1.3% 31,190 21,958 $227K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 1.3% 1,749 1,590 $225K
199 more codes
71045 Radiologic examination, chest; single view 1.3% 11,490 $219K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 1,766 $170K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 15,143 $165K
77067 Screening mammography, bilateral, including computer-aided detection <1% 2,710 $155K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 3,590 $152K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 28,843 $150K
81025 <1% 11,038 $110K
71046 Radiologic examination, chest; 2 views <1% 4,018 $103K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 1,563 $100K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 9,329 $91K
76830 Ultrasound, transvaginal <1% 1,072 $81K
82948 <1% 8,430 $75K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 2,053 $63K
OP251 <1% 8,504 $62K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 4,258 $59K
96361 Intravenous infusion, hydration; each additional hour <1% 3,070 $57K
93970 <1% 578 $55K
96375 Therapeutic injection; each additional sequential IV push <1% 6,805 $54K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 4,931 $49K
84484 <1% 11,297 $49K
OP272 <1% 17,144 $49K
73630 <1% 1,500 $48K
J7030 Infusion, normal saline solution , 1000 cc <1% 9,144 $47K
78815 Positron emission tomography (PET) for limited area imaging <1% 155 $47K
83735 <1% 16,595 $46K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 1,576 $44K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,477 $44K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 6,570 $42K
36415 Collection of venous blood by venipuncture <1% 13,023 $40K
90791 Psychiatric diagnostic evaluation <1% 1,405 $34K
83880 <1% 3,087 $31K
84443 Thyroid stimulating hormone (TSH) <1% 3,504 $31K
85610 <1% 11,327 $31K
85730 <1% 10,731 $28K
80061 Lipid panel <1% 3,126 $27K
73610 <1% 1,026 $26K
93971 <1% 378 $26K
82550 <1% 6,778 $24K
96376 <1% 3,619 $24K
86850 <1% 2,898 $24K
OP710 <1% 1,815 $23K
73560 <1% 918 $23K
83615 <1% 6,545 $22K
0012A <1% 749 $22K
73030 <1% 1,025 $22K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,339 $19K
0011A <1% 773 $19K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 661 $19K
83992 <1% 2,010 $19K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 779 $19K
72125 Computed tomography, cervical spine; without contrast material <1% 408 $18K
80048 Basic metabolic panel (calcium, ionized) <1% 2,837 $18K
OP270 <1% 12,631 $18K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 3,152 $17K
72110 <1% 592 $16K
85027 <1% 4,311 $16K
82803 <1% 2,824 $15K
87086 Culture, bacterial; quantitative colony count, urine <1% 6,591 $15K
86900 <1% 2,905 $14K
77080 <1% 303 $14K
87040 <1% 3,308 $13K
80361 <1% 1,995 $13K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 173 $13K
84100 <1% 7,223 $13K
81001 <1% 4,831 $12K
80345 <1% 1,993 $12K
80349 <1% 1,987 $12K
80353 <1% 1,991 $12K
83036 Hemoglobin; glycosylated (A1C) <1% 2,598 $11K
80346 <1% 1,988 $11K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 2,744 $11K
83690 <1% 7,033 $11K
70551 Magnetic resonance imaging, brain; without contrast material <1% 86 $11K
80324 <1% 2,000 $11K
73130 <1% 634 $11K
71275 Computed tomographic angiography, chest, with contrast material <1% 180 $11K
80358 <1% 1,990 $10K
70486 <1% 143 $10K
93458 <1% 42 $10K
87070 <1% 3,352 $10K
81003 <1% 10,475 $10K
80320 <1% 1,664 $10K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,024 $9K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 625 $9K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 51 $9K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 1,194 $8K
76641 <1% 113 $8K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 960 $8K
87430 <1% 2,273 $8K
OP370 <1% 2,088 $8K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 8,295 $7K
84702 <1% 1,431 $7K
99213 Doctor's office visit, returning patient (routine) <1% 447 $7K
96367 <1% 296 $7K
29581 <1% 886 $6K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 434 $6K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 625 $6K
82607 <1% 712 $6K
83550 <1% 1,770 $6K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 5,151 $6K
87181 <1% 1,813 $5K
82728 <1% 1,635 $5K
83540 <1% 1,967 $5K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 95 $5K
OP258 <1% 3,392 $5K
97161 <1% 552 $5K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 5,707 $5K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 89 $4K
80329 <1% 696 $4K
84439 <1% 584 $4K
99152 <1% 477 $4K
84703 <1% 2,408 $4K
76770 <1% 70 $4K
71250 <1% 74 $4K
C1769 Guide wire <1% 448 $3K
29580 <1% 1,163 $3K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 248 $3K
90715 <1% 853 $3K
82746 <1% 443 $3K
73562 <1% 238 $3K
85378 <1% 1,985 $3K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 144 $3K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 445 $3K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 12 $2K
73110 <1% 170 $2K
0031A <1% 79 $2K
C9113 Injection, pantoprazole sodium, per vial <1% 1,691 $2K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 855 $2K
M0222 Intravenous injection, bebtelovimab, includes injection and post administration monitoring <1% 17 $2K
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 250 $2K
93880 <1% 29 $2K
82553 <1% 524 $2K
97802 <1% 17 $2K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,816 $2K
87807 <1% 555 $2K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,918 $2K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 637 $1K
77065 Tomosynthesis, mammo <1% 27 $1K
76536 <1% 14 $1K
73590 <1% 25 $1K
J2785 Injection, regadenoson, 0.1 mg <1% 289 $1K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 12 $1K
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 241 $1K
77063 Screening digital breast tomosynthesis, bilateral <1% 78 $1K
73502 <1% 77 $994.04
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 839 $901.88
88342 <1% 49 $884.28
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 321 $817.66
73140 <1% 63 $798.62
93226 <1% 26 $734.61
97116 <1% 364 $676.74
97803 <1% 13 $655.92
J2704 Injection, propofol, 10 mg <1% 1,474 $646.62
84550 <1% 673 $640.71
93225 <1% 26 $607.93
77066 Tomosynthesis, mammo <1% 15 $581.56
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 776 $559.89
76642 <1% 12 $527.98
72050 <1% 16 $417.85
0064A <1% 12 $401.60
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,576 $392.92
J1650 Injection, enoxaparin sodium, 10 mg <1% 1,171 $330.53
74018 <1% 12 $322.83
J1170 Injection, hydromorphone, up to 4 mg <1% 920 $321.24
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 16 $309.62
A6449 Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard <1% 605 $289.81
86703 <1% 45 $271.96
84145 <1% 75 $269.01
83605 <1% 156 $242.73
82150 <1% 218 $242.23
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 41 $241.63
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 195 $237.75
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 971 $231.76
85651 <1% 401 $188.72
82248 <1% 134 $155.01
J1644 Injection, heparin sodium, per 1000 units <1% 1,308 $142.96
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 13 $139.84
73080 <1% 16 $133.77
J1756 Injection, iron sucrose, 1 mg <1% 96 $133.69
C1760 Closure device, vascular (implantable/insertable) <1% 40 $130.12
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,346 $118.89
OP271 <1% 133 $92.39
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,014 $66.75
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,015 $66.50
72100 <1% 14 $44.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 36 $41.82
86140 <1% 125 $40.32
J2060 Injection, lorazepam, 2 mg <1% 596 $37.54
86592 <1% 13 $36.12
82570 <1% 12 $29.82
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 91 $14.42
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 36 $12.12
J0690 Injection, cefazolin sodium, 500 mg <1% 176 $12.02
99153 Mod sedat endo service >5yrs <1% 28 $10.12
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 12 $7.98
J2470 Injection, pantoprazole sodium, 40 mg <1% 54 $6.60
J7510 Prednisolone oral, per 5 mg 0% 31 $0.00
91303 0% 27 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRODRIGUEZ, FRANK (SYSTEM DIRECTOR OF MEDICAL STAFF)
Same official

Other billing entities under RODRIGUEZ, FRANK

Full network →
ProviderLocationPaid
Humc Opco LLCHoboken, NJ$57.36M
Hudson Hospital Opco LLCJersey City, NJ$52.54M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.